Capgemini Shares Drop 2.11% at Close on Tuesday in a Cautious Market

Market Performance and Share Adjustments

Capgemini's stock closed this Tuesday at 141.40 euros, down 2.11% from the previous day's close of 144.45 euros. Trading volumes remained modest with 0.19% of the capital traded, reflecting a year-end session marked by investor caution. This correction is part of a consolidation movement that began a week ago, with the stock having fallen 4.91% over seven days, after jumping nearly 27% between October and mid-December. Over three months, the performance remains solidly positive with a gain of 15.95%, driven by the upward revision of the group's annual targets at the end of October and renewed investor confidence in the 2026 outlook. However, over the past year, the stock has still lost 8.92%, hampered by a challenging environment for IT services and persistent price pressures in an uncertain macroeconomic context. The decline observed this Tuesday occurred without any major news catalyst, suggesting a natural profit-taking after the recent sharp rise. On December 18, the group announced that its share capital now stands at 169,928,671 shares, down by 1,418,800 shares from December 31, 2024, a reduction of 0.8%. This operation results from the cancellation of 4,118,800 treasury shares and the capital increase linked to the employee share ownership plan, increasing the employees' share to around 8% of the capital. The stock is now trading above its 50-day moving average, set at 134.09 euros, and its 200-day moving average, positioned at 134.89 euros, confirming an overall bullish technical structure despite the ongoing consolidation.

Supporting Factors and Medium-Term Outlook

Several fundamental elements support the stock in the medium term. In two months, the stock has regained 27%. The group has raised its organic growth forecast for 2025 to between 2% and 2.5%, from an initial range of -1% to +1%, after third-quarter results exceeded expectations. The twelfth employee share ownership plan has crossed the threshold of 100,000 active participants in 36 countries for the first time, reflecting the confidence the teams place in the group's strategy and ambition. This commercial momentum, particularly in artificial intelligence offerings and in North America, strengthens expectations for 2026. Regarding recommendations, J.P. Morgan resumed coverage of the stock on December 11 with a neutral recommendation and a target price set at 155 euros, offering an upside potential of 9.6% from the current price of 141.40 euros. Analysts at Citi note that the stock is trading at a historically high discount compared to its peers, offering an attractive entry point for investors looking for recovery values. However, the group's management has tempered enthusiasm by mentioning a still challenging market environment in the fourth quarter, which could explain the short-term caution of investors.

Technical Indicators and Market Volatility

The RSI at 62 is in neutral territory, after reaching extreme overbought levels at 90 on December 11, indicating a gradual normalization of technical conditions. This indicator, which measures the relative strength of movement, suggests that the ongoing correction could be a healthy breather before a possible rebound. The MACD shows a slightly bearish configuration in the short term with a line at 3.97 below its signal line at 4.29, and a negative histogram at -0.32, confirming a slight weakening of the bullish momentum. This technical configuration calls for caution in the immediate future, even though the MACD remains in positive territory, preserving the underlying trend. The Bollinger Bands illustrate the recent volatility of the stock, with an upper bound at 154.41 euros and a lower bound at 130.86 euros. The current price at 141.40 euros is located in the middle part of this range, suggesting a temporary balance between buyers and sellers. The major resistance threshold is at 151.85 euros, a level tested in mid-December, while the key support is established at 127.05 euros, offering a safety margin of nearly 10% in case of a more marked correction. The one-month volatility stands at 7.08%, reflecting recent movements, while the limited beta at 0.26 shows a low correlation with the market. The upcoming sessions will be decisive in confirming or refuting the stock's ability to resume its progression towards the 155 euro target. The financial calendar schedules the publication of the 2025 annual results on February 13, 2026, a milestone that could crystallize investor expectations on the group's growth trajectory.